French Cohort of Patients With Rotator Cuff Lesions
Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Apr 15, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how different factors affect the recovery of patients with severe shoulder injuries known as transfixing rotator cuff lesions. Specifically, the study aims to see how these injuries impact shoulder function and quality of life after five years of treatment. By gathering information from participants, researchers hope to identify what helps people improve their shoulder health and overall well-being.
To be eligible for this study, participants must be adults aged 18 and older with a confirmed diagnosis of a total rotator cuff injury. They should also be able to communicate and provide feedback through online questionnaires. However, older adults over 75, those who have had previous shoulder surgeries, or individuals unable to participate due to legal protections will not be included. If you join the trial, you can expect to share your experiences and complete some online surveys about your shoulder function and daily life. This research aims to help improve treatment options for future patients with similar injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient, male or female, over 18 years of age.
- • Patient with a transfixing (total) rotator cuff lesion confirmed by imaging.
- • A patient who has been informed and has expressed no oral objection to taking part in the research.
- • Patient affiliated to or benefiting from a social security scheme.
- Exclusion Criteria:
- • Patients over 75 years of age.
- • Patients with a history of shoulder surgery.
- • Patients unable to receive emails and/or answer online questionnaires.
- • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.
About Gcs Ramsay Santé Pour L'enseignement Et La Recherche
GCS Ramsay Santé pour l'Enseignement et la Recherche is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and education. As a collaborative group, it unites academic institutions and healthcare professionals to facilitate high-quality clinical trials that enhance patient care and contribute to medical knowledge. With a focus on rigorous scientific standards and ethical practices, GCS Ramsay Santé plays a crucial role in the development of new therapies and treatment protocols, ensuring that cutting-edge research translates into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported